Snowflake Inc. (SNOW)’s Shares Higher After Jim Cramer Said It Was A Buy
Yahoo Finance ·
Snowflake Inc. (SNOW)’s Shares Higher After Jim Cramer Said It Was A Buy Ramish Cheema Sun, July 5, 2026 at 7:13 AM EDT 2 min read SNOW AMZN We recently published Jim Cramer's Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026 . Snowflake Inc. (NYSE:SNOW) is one of the stocks discussed by Jim Cramer. Data warehousing firm Snowflake Inc. (NYSE:SNOW)'s shares are up by 17.5% over the past year and by 20% year-to-date. Since Cramer's remarks, they are up by 15.9% with the most notable period coming between May 27th and June 1st, when the stock gained 59.8%. The stock surged by 36% on Thursday after Snowflake Inc. (NYSE:SNOW) guided $1.415 billion to $1.420 billion in fiscal second-quarter product revenue, which was higher than the $1.37 billion that analysts had penciled in. Additionally, it also announced a partnership with Amazon and beat analyst estimates for fiscal first quarter earnings and revenue. The results fell in line with Cramer's remarks on Mad Money, where he had discussed Snowflake Inc. (NYSE:SNOW) after its previous earnings release: "I have to tell you, I thought the quarter wasn't that bad… I was quite surprised about the negative reaction. You know it is a highly valued company, but I think Sridhar Ramaswamy is a terrific CEO, and I think the stock is, quite frankly, a buy." While we acknowledge the potential of SNOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock . READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy . Disclosure: None. Follow Insider Monkey on Google News .
DYAX Investor Sentiment
Bullish (Long) 56% · Bearish (Short) 44%
477 participants
Related News
- SpaceX bandwagon gets two new engines this week
- Notable healthcare headlines for the week: Abbott, AstraZeneca, and Eli Lilly in focus
- 80% of retirees are sitting on their nest eggs too long — and a new $6,000 tax break is slipping away
- Where Will Alphabet Stock Be in 5 Years?
- How to Get Exposure to OpenAI Before Its IPO
- AI bubble fears, the endless K-shaped economy, and insane hyperscaler capex spending